in the news

Newsroom
No items found.
Showing
1–25
of 100
Sort
Mar 1, 2023
Video
[ExtERNAL]
NYSE The Cure(ious): The Future of Health
Feb 22, 2023
Podcast
[ExtERNAL]
PharmaVoice Woman of the Week Podcast: Alltrna’s Michelle Werner
Nov 4, 2022
Award
[ExtERNAL]
C&EN: 10 Start-Ups to Watch for 2022
Jul 28, 2022
Article
[ExtERNAL]
Business Insider: Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs
Apr 11, 2022
Article
[ExtERNAL]
Endpoints Exclusive: Flagship snags another CEO-partner, on a personal mission, to lead its tRNA boat
Feb 23, 2022
Podcast
[ExtERNAL]
Biotech 2050: Episode 91 Alltrna
Nov 15, 2021
Article
[ExtERNAL]
Barron’s: A New Start-Up Explores Another Genome for Medicines
Nov 9, 2021
Article
[ExtERNAL]
Boston Business Journal: With $50M, Flagship Pioneering makes another big RNA play: Alltrna
Nov 9, 2021
Article
[ExtERNAL]
BioPharma Dive: Moderna founder unveils new drug company focused on a different kind of RNA
Nov 9, 2021
Article
[ExtERNAL]
BioSpace: Flagship Debuts Alltrna to Unlock the Mysteries of tRNA
Nov 9, 2021
Article
[ExtERNAL]
C&EN: Alltrna launches with $50 million for tRNA therapies
Nov 9, 2021
Article
[ExtERNAL]
Boston Globe: Flagship Pioneering unveils another RNA startup, backing it with $50 million
Nov 9, 2021
Article
[ExtERNAL]
Endpoints: A new Flagship startup looks to crack tRNA biology in search for completely new class of therapeutics
Nov 9, 2021
Article
[ExtERNAL]
Fierce Biotech: Flagship unveils its next RNA bet with $50M for Alltrna to explore thousands of genetic diseases using transfer RNA
Nov 9, 2021
Article
[ExtERNAL]
MedCity News: Flagship’s next genetic meds startup has $50M for transfer at a critical protein stop